4595-26-0

Usage

Chemical Class

Organic compounds; specifically, benzene and substituted derivatives.

Primary Use

Skincare and cosmetic products.

Function

Antioxidant: Protects skin from damage caused by free radicals and UV radiation.
Skin-conditioning agent: Helps maintain skin hydration and overall health.

Source

Naturally occurring form of vitamin E, commonly derived from vegetable oils.

Additional Uses

Food additive: Prolongs the shelf life of products.

Versatility

Valuable chemical in skincare, cosmetic, and food industries.

Upstream product

• 112-82-3 hexadecanyl bromide 
• 675141-80-7 1,4-diethoxy-2-hexadecyl-benzene 

Downstream Products

• 122142-80-7 hexadecyl-[1,4]benzoquinone 

Relevant academic research and scientific papers

HYDROQUINONE LONG-CHAIN DERIVATIVE AND/OR PHENOXY LONG-CHAIN DERIVATIVE, AND PHARMACEUTICAL PREPARATION COMPRISING THE SAME

The present invention provides compounds represented by formula (1) shown below: (wherein R1, R2, R3, R4, and R5 are each individually selected from among a hydrogen atom, methyl group, acetyl group, hydroxyl group, and alkoxy group; and X represents an alkylene group or alkenylene group); and compounds represented by formula (2) shown below: (wherein R6, R7, R8, R9, and R10 are each individually selected from among a hydrogen atom, alkyl group, acetyl group, hydroxyl group, and alkoxy group; A represents an oxygen atom or NH, and m is 0 or 1; and Y represents an alkylene group or alkenylene group, and Z represents a hydrogen atom or hydroxyl group).The compounds of the present invention are useful for preventing or treating brain dysfunctions, motor dysfunctions, or urinary dysfunctions caused by the degeneration and/or loss of the central nervous system or peripheral nervous system cells.The present invention provides compounds represented by formula (1) shown below: (wherein R 1 , R 2 , R 3 , R 4 , and R 5 are each individually selected from among a hydrogen atom, methyl group, acetyl group, hydroxyl group, and alkoxy group; and X represents an alkylene group or alkenylene group); and compounds represented by formula (2) shown below: (wherein R 6 , R 7 , R 8 , R 9 , and R 10 are each individually selected from among a hydrogen atom, alkyl group, acetyl group, hydroxyl group, and alkoxy group; A represents an oxygen atom or NH, and m is 0 or 1; and Y represents an alkylene group or alkenylene group, and Z represents a hydrogen atom or hydroxyl group). The compounds of the present invention are useful for preventing or treating brain dysfunctions, motor dysfunctions, or urinary dysfunctions caused by the degeneration and/or loss of the central nervous system or peripheral nervous system cells.

Method for C-alkylating hydroxylated aromatic compounds

PCT No. PCT/FR96/01722 Sec. 371 Date Aug. 31, 1998 Sec. 102(e) Date Aug. 31, 1998 PCT Filed Oct. 31, 1996 PCT Pub. No. WO97/16402 PCT Pub. Date May 9, 1997A method for C-alkylating a hydroxylated aromatic compound having at least one hydrogen atom in the ortho or para position relative to the hydroxyl grouping, wherein the aromatic compound is exposed to a proton acid and a compound causing the formation of a carbo-cation in the presence of the acid, and the reaction is performed in the presence of a solvent consisting of a water-alcohol pair.

Novel cytotoxic, alkylated hydroquinones from Lannea welwitschii

Two novel natural products, lanneaquinol (1) and 2'(R)- hydroxylanneaquinol (2), were isolated from the organic extract of the plant Lannea welwitschii (Hiern) Engl. Their structures were solved by spectroanalytical methods and confirmed by comparison to